Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ian Wilson and Andrew Ward.
Connection Strength

3.332
  1. The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev. 2017 01; 275(1):21-32.
    View in: PubMed
    Score: 0.698
  2. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science. 2021 08 13; 373(6556):818-823.
    View in: PubMed
    Score: 0.237
  3. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe. 2021 05 12; 29(5):806-818.e6.
    View in: PubMed
    Score: 0.235
  4. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. PLoS Pathog. 2020 12; 16(12):e1009089.
    View in: PubMed
    Score: 0.229
  5. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. 2020 12 15; 53(6):1272-1280.e5.
    View in: PubMed
    Score: 0.229
  6. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep. 2020 10 20; 33(3):108274.
    View in: PubMed
    Score: 0.226
  7. Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer. Nat Commun. 2018 05 16; 9(1):1956.
    View in: PubMed
    Score: 0.192
  8. Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci U S A. 2017 11 28; 114(48):E10438-E10445.
    View in: PubMed
    Score: 0.185
  9. In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity. Nat Commun. 2017 05 15; 8:15371.
    View in: PubMed
    Score: 0.179
  10. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic ß-Hairpin Structure. Immunity. 2017 04 18; 46(4):690-702.
    View in: PubMed
    Score: 0.178
  11. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat Commun. 2020 05 27; 11(1):2688.
    View in: PubMed
    Score: 0.055
  12. HIV-1 vaccine design through minimizing envelope metastability. Sci Adv. 2018 11; 4(11):eaau6769.
    View in: PubMed
    Score: 0.050
  13. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization. Immunity. 2018 08 21; 49(2):288-300.e8.
    View in: PubMed
    Score: 0.049
  14. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 07 10; 9(1):2669.
    View in: PubMed
    Score: 0.049
  15. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog. 2018 02; 14(2):e1006913.
    View in: PubMed
    Score: 0.047
  16. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. J Proteome Res. 2018 03 02; 17(3):987-999.
    View in: PubMed
    Score: 0.047
  17. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Rep. 2018 01 23; 22(4):1103.
    View in: PubMed
    Score: 0.047
  18. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers. J Biol Chem. 2018 02 02; 293(5):1688-1701.
    View in: PubMed
    Score: 0.047
  19. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Rep. 2017 Oct 03; 21(1):222-235.
    View in: PubMed
    Score: 0.046
  20. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J Exp Med. 2017 Sep 04; 214(9):2573-2590.
    View in: PubMed
    Score: 0.046
  21. Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers. Sci Rep. 2017 08 21; 7(1):8390.
    View in: PubMed
    Score: 0.046
  22. Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers. J Virol. 2017 08 01; 91(15).
    View in: PubMed
    Score: 0.045
  23. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity. 2017 06 20; 46(6):1073-1088.e6.
    View in: PubMed
    Score: 0.045
  24. Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. J Virol. 2017 06 15; 91(12).
    View in: PubMed
    Score: 0.045
  25. Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein. Immunity. 2017 05 16; 46(5):792-803.e3.
    View in: PubMed
    Score: 0.045
  26. A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union. Science. 2014 Feb 07; 343(6171):656-661.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.